LIXTW Projected Dividend Yield

Wt Exp 01/01/2025/Lixte Biotechnology Holdings, Inc. ( NASDAQ : LIXTW )

Lixte Biotechnology Holdings, Inc. is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. Co.'s product pipeline is primarily focused on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers. Co. encompasses that inhibitors of protein phosphatases have broad therapeutic potential not only for cancer but also for other debilitating and life-threatening diseases. It is focused on development activities of its LB-100 series of drugs.

20 YEAR PERFORMANCE RESULTS